Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Map
Live
Schedule
Daily Record
Special Rules
Subpoenas
Foreign Influence
Agencies
Regulations
Office Spending
US Code
Open search

Federal Regulations

How Congress's laws become real-world rules. Browse regulatory dockets from Regulations.gov — tracking rulemaking activity, public comment periods, and the agencies turning legislation into policy.

Dockets
6,215
Regulations.gov

Showing 30 of 6,215 dockets

Nonrulemaking
FDA
Open for Comments

FDA-2025-P-1242

Request that the FDA immediately suspend the approval of mifepristone (brand name: Mifeprex) for use in chemical abortions until a comprehensive safety review can be conducted under current real-world prescribing conditions.

4 docs7 comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-1025

Request that the FDA take the following four actions: 1) Mandate Warning Labels: Require infant formula products to carry prominent warnings informing consumers that introducing formula can reduce breastmilk production due to decreased infant suckling, which is essential for maintaining lactation 2) Regulate Marketing Claims: Prohibit marketing language that suggests formula is designed to

3 docs19 comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-0876

Request that the FDA amend the labeling regulations for infant formula, including specialty formulas, to require the following warnings on all packaging and marketing materials: “Formula feeding increases the risk of infections-such as ear infections, diarrhea, lower respiratory infections

3 docs15 comments
Nonrulemaking
OSHA
Open for Comments

OSHA-2010-0041

Logging Operations (29 CFR 1910.266). OMB Control Number 1218-0198

15 docs1 comment
Comments due May 27, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2026-P-3844

Requests that the FDA declare that the drug products Desmopressin Acetate Tablets, 0.05 mg and 0.15 mg, are suitable for consideration in an Abbreviated New Drug Application.

5 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-3269

DAB Civil Money Penalty; 418 West Dickson Street, LLC d/b/a Always 420 King Tobacco Smoke Shop

1 docNo comments
Rulemaking
FAA

FAA-2026-1336

MCAI-2025-00254-T; Airbus Canada Limited Partnership (ACLP) Model BD-500-1A10 and BD-500-1A11 series airplanes; Electronic Engine Control (EEC) Software

2 docs2 comments
Rulemaking
FAA
Open for Comments

FAA-2026-2296

MCAI-2025-01794-T; Airbus SAS Models A319/A320/A321 airplanes; AFM Normal Procedure Ground Engine Operation in Icing Condition – Amendment

1 doc1 comment
Comments due Apr 25, 2026
Rulemaking
NOAA

NOAA-NMFS-2025-0036

Atlantic Highly Migratory Species; Revision of the Termination Date for Swordfish and Shark Limited Access Permits

2 docs5 comments
Nonrulemaking
EPA
Open for Comments

EPA-HQ-OPP-2023-0557

Notice of Receipt of a Application for the Registration of a Microbial Pesticide

6 docs2 comments
Comments due Apr 25, 2026
Nonrulemaking
FDA

FDA-2026-H-1031

DAB Civil Money Penalty; Dominican Deli Mini Market LLC d/b/a Dominican Deli Mini Market; CLOSED 04/09/2026

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-P-0377

Request that FDA remove the Mifepristone Shared System REMS Program, including but not limited to the three ETASU requiring prescriber certification, pharmacy certification, and a patient agreement form

10 docs246 comments
Nonrulemaking
FDA

FDA-2025-N-6869

Agency Information Collection Activities; Proposed Collection; Comment Request; Medication Guides for Prescription Drug Products

1 doc5 comments
Nonrulemaking
ED
Open for Comments

ED-2026-SCC-0331

State Education Agency, Local Educational Agency, and School Data Collection and Reporting under ESEA, Title I, Part A

3 docs1 comment
Comments due Apr 28, 2026
Nonrulemaking
ED
Open for Comments

ED-2026-SCC-0562

Shaping the Future of Loan Repayment

3 docs3 comments
Comments due May 19, 2026
Nonrulemaking
FDA

FDA-2024-H-5840

DAB Civil Money Penalty; Zeigler Petro Inc. d/b/a Marathon; CLOSED 04/09/2026

1 docNo comments
Rulemaking
AMS

AMS-SC-25-0617

Sweet Cherries Grown in Designated Counties in Washington; Modification of Handling Regulations

1 doc9 comments
Nonrulemaking
FDA

FDA-2025-H-3250

DAB Civil Money Penalty; Hills Liquor 5, Inc. d/b/a Hills 5 Liquors; CLOSED 4/09/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-0908

DAB Civil Money Penalty; CLC GlenRo Spirit Shoppe LLC d/b/a GlenRo Spirit Shoppe; CLOSED 04/09/2026

1 docNo comments
Rulemaking
ACF
Open for Comments

ACF-2026-0331

Reducing Bureaucracy and Burden for Community Services Programs

1 docNo comments
Comments due May 9, 2026
Nonrulemaking
FDA

FDA-2025-H-1978

DAB Civil Money Penalty; West Coast Vape Supply, Inc. d/b/a West Coast Vape Supply; CLOSED 04/09/2026

1 docNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2022-0670

Chantilly Air - Exemption/Rulemaking

8 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3371

Golden Specialty Drone Solutions, LLC - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3730

Triple B Drone Services, LLC - Exemption/Rulemaking

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-0111

DAB Civil Money Penalty; Eunhye YS Corporation, d/b/a 777 Liquors, Grocery & Gift Shop; CLOSED 04/09/2026

1 docNo comments
Rulemaking
FDA
Open for Comments

FDA-2025-N-5996

Medical Devices; Radiology Devices; Classification of Blood Irradiators

35 docs2 comments
Comments due May 19, 2026
Nonrulemaking
FDA

FDA-2026-H-2312

DAB Civil Money Penalty; Star Mart 1 LLC d/b/a Star Mart 1; CLOSED 04/09/2026

1 docNo comments
Nonrulemaking
FDA
Open for Comments

FDA-2025-D-2275

M4Q(R2) The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality; International Council for Harmonisation; Draft Guidance for Industry; Availability

2 docs18 comments
Comments due Mar 24, 2026
Nonrulemaking
FDA
Open for Comments

FDA-2025-D-1797

E21 Inclusion of Pregnant and Breastfeeding Women in Clinical Trials; International Council for Harmonisation; Draft Guidance for Industry; Availability

2 docs29 comments
Comments due Sep 20, 2025
Nonrulemaking
FDA
Open for Comments

FDA-2025-D-1504

Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability

2 docs13 comments
Comments due May 9, 2026
  • Previous
  • Page 74 of 208
  • Next